Letter by Terao et al Regarding Article, “Damage to the Left Precentral Gyrus Is Associated With Apraxia of Speech in Acute Stroke”

Terao, Yasuo; Sakurai, Yasuhisa; Ugawa, Yoshikazu

doi:10.1161/strokeaha.116.012755

Cited by 4 publications

(5 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This suggests that recovery of motor speech planning, which is lateralized to the left hemisphere [8], depends, at least partially, on the function of contralesional homologue areas. Our findings are also in line with results obtained in healthy subjects, showing that motor speech production, although lateralized towards the dominant hemisphere, relies on motor cortical networks of both hemispheres [2]. Regarding the future of AOS therapy, our results further suggest that inhibition of contralesional homologue areas should probably be avoided.…”

supporting

confidence: 91%

“…AOS is most often accompanied by aphasia, whereas isolated forms may rarely occur after focal damage to the left precentral gyrus [1]. How AOS recovers after brain damage is poorly understood [2]. In particular, it is not known whether recovery of AOS solely depends on the functional reorganisation of perilesional areas [3,4], or whether it also depends on the compensation through contralesional homologue areas.…”

mentioning

confidence: 99%

“…In particular, it is not known whether recovery of AOS solely depends on the functional reorganisation of perilesional areas [3,4], or whether it also depends on the compensation through contralesional homologue areas. Based on findings from healthy subjects showing that speech production is controlled by both hemispheres [2], it may be hypothesized that the contralesional homologue areas contribute to recovery of AOS.…”

mentioning

confidence: 99%

See 2 more Smart Citations

cTBS over contralesional homologue areas deteriorates speech output in isolated apraxia of speech after stroke

et al. 2019

View full text Add to dashboard Cite

supporting

confidence: 91%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

cTBS over contralesional homologue areas deteriorates speech output in isolated apraxia of speech after stroke

et al. 2019

View full text Add to dashboard Cite

“…PLD3 has been reported to be involved in myogenesis [451]. PLD4 is described not to have phospholipase D catalytic activity [665], but has been associated with inflammatory disorders [447,574,593]. Sequence analysis suggests that PLD5 is catalytically inactive.…”

Section: Commentsmentioning

confidence: 99%

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes

Alexander

Fabbro

Kelly

et al. 2019

British J Pharmacology

472

431

View full text Add to dashboard Cite

The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (http://www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point‐in‐time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.14752. Enzymes are one of the six major pharmacological targets into which the Guide is divided, with the others being: G protein‐coupled receptors, ion channels, nuclear hormone receptors, catalytic receptors and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid‐2019, and supersedes data presented in the 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification (NC‐IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.

show abstract

“…PLD3 has been reported to be involved in myogenesis [522]. PLD4 is described not to have phospholipase D catalytic activity [765], but has been associated with inflammatory disorders [518,659,679]. Sequence analysis suggests that PLD5 is catalytically inactive.…”

Section: Further Reading Onmentioning

confidence: 99%

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes

Alexander

Fabbro

Kelly

et al. 2021

British J Pharmacology

367

288

View full text Add to dashboard Cite

The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (https://www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes over 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point‐in‐time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/bph.15542. Enzymes are one of the six major pharmacological targets into which the Guide is divided, with the others being: G protein‐coupled receptors, ion channels, nuclear hormone receptors, catalytic receptors and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid‐2021, and supersedes data presented in the 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC‐IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.

show abstract

Letter by Terao et al Regarding Article, “Damage to the Left Precentral Gyrus Is Associated With Apraxia of Speech in Acute Stroke”

Cited by 4 publications

References 5 publications

cTBS over contralesional homologue areas deteriorates speech output in isolated apraxia of speech after stroke

cTBS over contralesional homologue areas deteriorates speech output in isolated apraxia of speech after stroke

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes

Contact Info

Product

Resources

About